- Home
- IMTX vs LZB Comparison
IMTX vs LZB Comparison
Compare IMTX & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMTX | LZB |
|---|---|---|
| Founded | N/A | 1927 |
| Country | Germany | United States |
| Employees | 407 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | N/A | 1994 |
Fundamental Metrics
Financial Performance| Metric | IMTX | LZB |
|---|---|---|
| Price | $11.19 | $33.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $19.00 | ★ $39.00 |
| AVG Volume (30 Days) | 273.8K | ★ 315.9K |
| Earning Date | 05-13-2026 | 06-16-2026 |
| Dividend Yield | N/A | ★ 2.75% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.65 |
| Revenue | N/A | ★ $2,349,433,000.00 |
| Revenue This Year | N/A | $1.89 |
| Revenue Next Year | $25.91 | $2.09 |
| P/E Ratio | ★ N/A | $21.20 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.94 | $29.03 |
| 52 Week High | $12.41 | $44.49 |
Technical Indicators
Market Signals| Indicator | IMTX | LZB |
|---|---|---|
| Relative Strength Index (RSI) | 56.47 | 43.95 |
| Support Level | $9.61 | $32.96 |
| Resistance Level | $11.41 | $33.90 |
| Average True Range (ATR) | 0.42 | 0.86 |
| MACD | -0.05 | -0.10 |
| Stochastic Oscillator | 52.53 | 9.32 |
Price Performance
Historical ComparisonAbout IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
About LZB La-Z-Boy Incorporated
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.